MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
The IL-17 family cytokines IL-17A and IL-17C drive the pathogenesis of psoriatic skin inflammation, and anti–IL-17A Abs were recently approved to treat human psoriasis. Little is known about mechanisms that restrain IL-17 cytokine-mediated signaling, particularly IL-17C. In this article, we show that the endoribonuclease MCP-1–induced protein 1 (MCPIP1; also known as regnase-1) is markedly upregulated in human psoriatic skin lesions. Similarly, MCPIP1 was overexpressed in the imiquimod (IMQ)-driven mouse model of cutaneous inflammation. Mice with an MCPIP1 deficiency (Zc3h12a+/−) displayed no baseline skin inflammation, but they showed exacerbated pathology following IMQ treatment. Pathology in Zc3h12a+/− mice was associated with elevated expression of IL-17A– and IL-17C–dependent genes, as well as with increased accumulation of neutrophils in skin. However, IL-17A and IL-17C expression was unaltered, suggesting that the increased inflammation in Zc3h12a+/− mice was due to enhanced downstream IL-17R signaling. Radiation chimeras demonstrated that MCPIP1 in nonhematopoietic cells is responsible for controlling skin pathology. Moreover, Zc3h12a+/−Il17ra−/− mice given IMQ showed almost no disease. To identify which IL-17RA ligand was essential, Zc3h12a+/−Il17a−/− and Zc3h12a+/−Il17c−/− mice were given IMQ; these mice had reduced but not fully abrogated pathology, indicating that MCPIP1 inhibits IL-17A and IL-17C signaling. Confirming this hypothesis, Zc3h12a−/− keratinocytes showed increased responsiveness to IL-17A and IL-17C stimulation. Thus, MCPIP1 is a potent negative regulator of psoriatic skin inflammation through IL-17A and IL-17C. Moreover, to our knowledge, MCPIP1 is the first described negative regulator of IL-17C signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this is concomitant with exacerbated autoimmunity in models of EAE and imiquimod-psoriasis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Monin et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans, Regnase-1 expression is elevated in psoriatic lesions and other conditions of IL-17-driven inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Monin et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas beneficial IL-17 signaling is enhanced in Regnase-1-deficient mouse settings, as demonstrated by heightened resistance to fungal infection”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Monin et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 1×
“stimulated with IL-17A upregulate antimicrobial peptides and neutrophil-attracting chemokines (43, 44).”
BackgroundImiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176 · cited 3×
“In the IMQ dermatitis model, IL-17RA–deficient mice show dramatically reduced disease development (31).”
BackgroundDevelopment, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 1×
“I n the past decade, IL-17 family members have emerged as drivers of inflammatory and autoimmune conditions, particularly psoriasis (1).”
BackgroundSelf-citationInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
Kronenberg, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115742 · Cited by 1,029
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Baeten, D., Sieper, J., Braun, J., Baraliakos, X., Dougados, M., Emery, P., Deodhar, A., Porter, B., Martin, R., Andersson, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505066 · Cited by 1,029
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V. R., Zhang, H.-G., Wang, T., Zheng, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.001 · Cited by 1,026
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024
Self-citationAnti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804 · cited 1×
“stimulated with IL-17A upregulate antimicrobial peptides and neutrophil-attracting chemokines (43, 44).”
BackgroundZc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
Matsushita, K., Takeuchi, O., Standley, D. M., Kumagai, Y., Kawagoe, T., Miyake, T., Satoh, T., Kato, H., Tsujimura, T., Nakamura, H., et al. (2009) · Nature · doi:10.1038/nature07924 · Cited by 649
The immunogenetics of Psoriasis: A comprehensive review
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.008 · Cited by 616 · cited 1×
“GWAS analysis of human psoriasis revealed associations with known regulators of immune signaling, including TNFAIP3 (A20), TNIP1 (ABIN-1, NAF1), and NFKBIA (IkBa) (61).”
BackgroundTeunissen, M. B. M., Bos, J. D., Koomen, C. W., de Waal Malefyt, R., & Wierenga, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 570 · cited 1×
“KCs are highly responsive to IL-17A and IL-17C (14, 40, 41).”
BackgroundA20: linking a complex regulator of ubiquitylation to immunity and human disease
Ma, A., & Malynn, B. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3313 · Cited by 548 · cited 1×
“given the role of MCPIP1 in restricting inflammation, it is common for feedback inhibitors like TNFAIP3 and TNIP1 to be associated with inflammation (67).”
BackgroundRorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
Pantelyushin, S., Haak, S., Ingold, B., Kulig, P., Heppner, F. L., Navarini, A. A., & Becher, B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61862 · Cited by 512 · cited 1×
“Vg4 gd T cells are a major source of IL-17A in IMQ-induced inflammation (35, 36).”
BackgroundInnate lymphoid cells in the initiation, regulation and resolution of inflammation
Sonnenberg, G. F., & Artis, D. (2015) · Nature Medicine · doi:10.1038/nm.3892 · Cited by 503
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., Hackney, J., Kim, J., Zhou, M., Lai, J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2156 · Cited by 477 · cited 1×
“IL-17C–deficient mice develop milder skin inflammation upon IMQ treatment (11).”
BackgroundLichti, U., Anders, J., & Yuspa, S. H. (2008) · Nature Protocols · doi:10.1038/nprot.2008.50 · Cited by 441
Mino, T., Murakawa, Y., Fukao, A., Vandenbon, A., Wessels, H.-H., Ori, D., Uehata, T., Tartey, S., Akira, S., Suzuki, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.029 · Cited by 390 · cited 2×
“1B), consistent with the known expression pattern of this protein (23).”
BackgroundVillanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G. K., Chapman, A., Smith, C. H., Di Meglio, P., & Nestle, F. O. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.477 · Cited by 386
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
Hüffmeier, U., Uebe, S., Ekici, A. B., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Apel, M., McManus, R., Ho, P., et al. (2010) · Nature Genetics · doi:10.1038/ng.688 · Cited by 371
Post-transcriptional regulation of gene expression in innate immunity
Carpenter, S., Ricci, E. P., Mercier, B. C., Moore, M. J., & Fitzgerald, K. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3682 · Cited by 367 · cited 1×
“To our knowledge this is the first report of a negative-regulatory element in the IL-17C signaling pathway, although it is not likely to be the last (60).”
BackgroundGenome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2
Ellinghaus, E., Ellinghaus, D., Stuart, P. E., Nair, R. P., Debrus, S., Raelson, J. V., Belouchi, M., Fournier, H., Reinhard, C., Ding, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.689 · Cited by 359
Self-citationCharacterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
Johansen, C., Usher, P. A., Kjellerup, R. B., Lundsgaard, D., Iversen, L., & Kragballe, K. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08902.x · Cited by 352 · cited 1×
“Elevated levels of IL-17A and IL-17C occur in lesional human psoriasis skin samples (14, 39, 42), and human KCs FIGURE 3.”
BackgroundMalt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation
Uehata, T., Iwasaki, H., Vandenbon, A., Matsushita, K., Hernandez-Cuellar, E., Kuniyoshi, K., Satoh, T., Mino, T., Suzuki, Y., Standley, D. M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.034 · Cited by 349 · cited 1×
“MCPIP1 deficiency in CD4 cells was shown to enhance Th17 effector function (26, 27).”
BackgroundKumar, P., Monin, L., Castillo, P., Elsegeiny, W., Horne, W., Eddens, T., Vikram, A., Good, M., Schoenborn, A. A., Bibby, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.007 · Cited by 326
Self-citationSong, X., Zhu, S., Shi, P., Liu, Y., Shi, Y., Levin, S. D., & Qian, Y. (2011) · Nature Immunology · doi:10.1038/ni.2155 · Cited by 312
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation
Johnston, A., Fritz, Y., Dawes, S. M., Diaconu, D., Al-Attar, P. M., Guzman, A. M., Chen, C. S., Fu, W., Gudjonsson, J. E., McCormick, T. S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201505 · Cited by 308 · cited 6×
“Elevated levels of IL-17A and IL-17C occur in lesional human psoriasis skin samples (14, 39, 42), and human KCs FIGURE 3.”
BackgroundInfluentialSelf-citationMCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
Liang, J., Saad, Y., Lei, T., Wang, J., Qi, D., Yang, Q., Kolattukudy, P. E., & Fu, M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092641 · Cited by 297 · cited 4×
“be used for experimentation because they exhibit severely shortened lifespans as a consequence of unrestricted TLR signaling and widespread inflammation (23, 28).”
BackgroundInfluentialJeltsch, K. M., Hu, D., Brenner, S., Zöller, J., Heinz, G. A., Nagel, D., Vogel, K. U., Rehage, N., Warth, S. C., Edelmann, S. L., et al. (2014) · Nature Immunology · doi:10.1038/ni.3008 · Cited by 274 · cited 3×
“Previously, MCPIP1 was shown to negatively regulate TCR signaling and IL-17A production by Th17 cells (27).”
BackgroundInterleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
Chang, S. H., Reynolds, J. M., Pappu, B. P., Chen, G., Martinez, G. J., & Dong, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.010 · Cited by 271
A Novel CCCH-Zinc Finger Protein Family Regulates Proinflammatory Activation of Macrophages
Liang, J., Wang, J., Azfer, A., Song, W., Tromp, G., Kolattukudy, P. E., & Fu, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707861200 · Cited by 252 · cited 1×
“In addition, ZC3H12C and ZC3H12A are induced in LPStreated macrophages (65), although it is not known whether ZC3H12C is an IL-17 target gene.”
BackgroundThe activation and regulation of IL-17 receptor mediated signaling
Song, X., & Qian, Y. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.014 · Cited by 206
Song, X., Gao, H., Lin, Y., Yao, Y., Zhu, S., Wang, J., Liu, Y., Yao, X., Meng, G., Shen, N., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.018 · Cited by 185
Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease
Tian, S., Krueger, J. G., Li, K., Jabbari, A., Brodmerkel, C., Lowes, M. A., & Suárez-Fariñas, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044274 · Cited by 183 · cited 1×
“1), consistent with published data (20, 66) and our data in mice (Fig.”
ResultIL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes-Duculan, J., Cardinale, I., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman-Yassky, E., Suárez-Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 180 · cited 1×
“KCs are highly responsive to IL-17A and IL-17C (14, 40, 41).”
BackgroundMarks, B. R., Nowyhed, H. N., Choi, J.-Y., Poholek, A. C., Odegard, J. M., Flavell, R. A., & Craft, J. (2009) · Nature Immunology · doi:10.1038/ni.1783 · Cited by 173
IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms
Ha, H.-L., Wang, H., Pisitkun, P., Kim, J.-C., Tassi, I., Tang, W., Morasso, M. I., Udey, M. C., & Siebenlist, U. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400513111 · Cited by 171 · cited 2×
“, KCs, endothelial cells, and skin fibroblasts) (32).”
Background[1] Isolation and utilization of epidermal keratinocytes for oncogene research
Dlugosz, A. A., Glick, A. B., Tennenbaum, T., Weinberg, W. C., & Yuspa, S. H. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)54003-2 · Cited by 158
IL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 146 · cited 1×
“Finally, MCPIP1 is a feedback inhibitor that degrades IL-17–induced target genes, including Il6, Nfkbiz, and transcripts encoding IL-17R subunits (18, 21, 58).”
BackgroundGarg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145 · cited 8×
“such as kidney and lung; rather, haploinsufficient cells failed to show ligand-inducible upregulation of MCPIP1 (18).”
BackgroundInfluentialSelf-citationZhu, S., Pan, W., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 138
IL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain
Shen, F., Li, N., Gade, P., Kalvakolanu, D. V., Weibley, T., Doble, B., Woodgett, J. R., Wood, T. D., & Gaffen, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000066 · Cited by 131 · cited 1×
“GSK-3b–mediated phosphorylation of the transcription factor C/EBPb inhibits IL-17–dependent gene expression (57).”
BackgroundSelf-citationThe deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128 · cited 1×
“The deubiquitinase A20 (TNFAIP3) is induced by IL-17A and mediates the removal of K63-linked ubiquitin chains on TRAF6, tempering activation of NF-kB and MAPK pathways (56).”
BackgroundSelf-citationSecukinumab: First Global Approval
Sanford, M., & McKeage, K. (2015) · Drugs · doi:10.1007/s40265-015-0359-0 · Cited by 118
USP10 inhibits genotoxic NF‐κB activation by MCPIP1‐facilitated deubiquitination of NEMO
Niu, J., Shi, Y., Xue, J., Miao, R., Huang, S., Wang, T., Wu, J., Fu, M., & Wu, Z. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.247 · Cited by 109 · cited 1×
“MCPIP1 regulates TLR signaling through cleavage of target gene mRNAs, including Il6 (22–24), or deubiquitination of inflammatory mediators (25).”
BackgroundNagata, T., Mckinley, L., Peschon, J. J., Alcorn, J. F., Aujla, S. J., & Kolls, J. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7473 · Cited by 99
Jura, J., Skalniak, Ł., & Koj, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.029 · Cited by 95
Lubberts, E., Schwarzenberger, P., Huang, W., Schurr, J. R., Peschon, J. J., van den Berg, W. B., & Kolls, J. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3360 · Cited by 85 · cited 1×
“only in the nonhematopoietic compartment (68).”
Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function
Ippagunta, S. K., Gangwar, R., Finkelstein, D., Vogel, P., Pelletier, S., Gingras, S., Redecke, V., & Häcker, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606996113 · Cited by 85 · cited 1×
“controls IL-17–induced pathology in IMQ-induced dermatitis (59).”
Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
Li, X.-X. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.015 · Cited by 78
Zepp, J. A., Liu, C., Qian, W., Wu, L., Gulen, M. F., Kang, Z., & Li, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200470 · Cited by 73
Liang, J., Wang, J., Saad, Y., Warble, L., Becerra, E., & Kolattukudy, P. E. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-182 · Cited by 61
Liu, L., Zhou, Z., Huang, S., Guo, Y., Fan, Y., Zhang, J., Zhang, J., Fu, M., & Chen, Y. E. (2013) · Biochemical Journal · doi:10.1042/bj20130019 · Cited by 50 · cited 1×
“responses in endothelial cells by suppressing NF-kB signaling (64).”
BackgroundMCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A
Ruiz‐Romeu, E., Ferrán, M., Giménez‐Arnau, A. M., Bugara, B., Lipert, B. A., Jura, J., Florencia, E. F., Prens, E. P., Celada, A., Pujol, R. M., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.04.030 · Cited by 50 · cited 2×
“1), consistent with published data (20, 66) and our data in mice (Fig.”
BackgroundResultContribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis
Durham, L. E., Kirkham, B. W., & Taams, L. S. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-015-0529-9 · Cited by 49
Association analysis of GWAS and candidate gene loci in a Pakistani population with psoriasis
Munir, S., Rahman, S. B., Rehman, S., Saba, N., Ahmad, W., Nilsson, S., Mazhar, K., & Naluai, Å. T. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.11.015 · Cited by 40 · cited 1×
“It is intriguing that polymorphisms in ZC3H12C (encoding MCP-1–induced protein 3) were identified in a GWAS study (48, 63).”
BackgroundCIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17
Somma, D., Mastrovito, P., Grieco, M., Lavorgna, A., Pignalosa, A., Formisano, L., Salzano, A. M., Scaloni, A., Pacifico, F., Siebenlist, U., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401589 · Cited by 36 · cited 1×
“Finally, MCPIP1 is a feedback inhibitor that degrades IL-17–induced target genes, including Il6, Nfkbiz, and transcripts encoding IL-17R subunits (18, 21, 58).”
BackgroundDhamija, S., Winzen, R., Doerrie, A., Behrens, G., Kühne, N., Schauerte, C., Neumann, E., Dittrich‐Breiholz, O., Kracht, M., & Holtmann, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452649 · Cited by 28
Sønder, S. U., Paun, A., Ha, H.-L., Johnson, P. F., & Siebenlist, U. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103233 · Cited by 27
Yang, C., Huang, S., Wang, X., & Gu, Y. (2015) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2015013022 · Cited by 26 · cited 1×
“MCPIP1 negatively regulates several inflammatory stimuli, but its role in psoriasis is poorly defined (18, 34).”
BackgroundZC3H12A (MCPIP1): Molecular characteristics and clinical implications
Cifuentes, R., Cruz‐Tapias, P., Rojas‐Villarraga, A., & Anaya, J. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.033 · Cited by 21 · cited 1×
“Eleven nonsynonymous single-nucleotide polymorphisms were reported for the ZC3H12A gene, but none are associated with human disease (62).”
BackgroundWohn, C., Pantelyushin, S., Ober-Blöbaum, J. L., & Clausen, B. E. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1212-4_16 · Cited by 9 · cited 1×
“This system is considered a good model of the early events in psoriatic plaque formation (33).”
Background
Research works printed but not linked: 2
- Gaffen SL Jain R Garg A Cua D 2014 IL-23-IL-17 immune axis: From mechanisms to therapeutic testing Nat Rev Immunol 14 585 600 25145755 PMC4281037
- Matsushita K Takeuchi O Standley DM Kumagai Y Kawagoe T Miyake T Satoh T Kato H Tsujimura T Nakamura H Akira S 2009 Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay Nature 458 1185 1190 19322177
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“In humans, Regnase-1 expression is elevated in psoriatic lesions and other conditions of IL-17-driven inflammation, indicating that its activity can be offset in inflammatory environments (Monin et al., 2017).”
BackgroundSelf-citationIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“while exacerbating IL-17-mediated pathology in mouse models of EAE, pulmonary inflammation and psoriasis [74, 95].”
BackgroundSelf-citationIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationThe IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
“In addition, IL-17C is upregulated in murine psoriasiform dermatitis (62, 92, 93), and IL-17C-deficient mice develop milder skin inflammation upon imiquimod application (96, 98).”
BackgroundMonin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
“We recently showed that the action of MCPIP1 can also curb IL-17C-mediated inflammation in murine keratinocytes both in vitro and in vivo, thereby limiting skin inflammation in the imiquimod-driven psoriasis model (Monin et al. 2017).”
BackgroundSelf-citation
Metadata
- Authors
- Monin, L., Gudjonsson, J. E., Childs, E. E., Amatya, N., Xing, X., Verma, A. H., Coleman, B. M., Garg, A. V., Killeen, M., Mathers, A., Ward, N. L., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- University of Michigan (US)
- Case Western Reserve University (US)
- Corresponding author
- Monin, Leticia
- Amatya, Nilesh
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01
- Volume
- 198
- Issue
- 2
- Pages
- 767-775
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC5225040
- OpenAlex
- W2560803412
- Cited by
- 82
- References
- 69
- Citations by year
- 2026: 8 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 13 · 2020: 10 · 2019: 11 · 2018: 7 · 2017: 10
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- National Institutes of Health (5r37de022550-12)
- Genentech
- National Institute of Allergy and Infectious Diseases (R01AI107825)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR039750, R01AR066548, R21AR063852, R01AR062546, R01AR063437, R01AR069071, R01AR067746)
- National Institute of Dental and Craniofacial Research (R37-DE022550, R01DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- MCPIP1, Regnase-1, ZC3H12A, IL-17A, IL-17C, psoriasis, IL-17 receptor signaling, imiquimod-induced skin inflammation, keratinocytes, neutrophil accumulation, endoribonuclease, negative regulation of cytokine signaling
- MeSH terms
- Animals, Dermatitis, Flow Cytometry, Humans, Immunohistochemistry, Psoriasis, Ribonucleases, Transcription Factors, Keratinocytes, Mice, Knockout, Interleukin-17, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.